2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow rifamycin SV: new trials by email Literature Review of rifamycin SV trials Research Report on rifamycin SV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum Women Rifapentine (RPT), Isoniazid (INH), Pyridoxine (vitamin B6) - Tuberculosis | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 50 | 2017-03-13 | 2021-11-04 |
| Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions Rifampicin, sulforaphane plus rifampicin, sulforaphane alone - Adverse Drug Interactions | Phase 1 | Completed | University of Washington | 29 | 2008-03-01 | 2019-09-06 |
Tuberculosis (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1) · University of Washington (1)
Haiti (1) · Kenya (1) · Malawi (1) · Thailand (1) · United States (1) · Zimbabwe (1)
David L Eaton, PhD (1) · Jyoti S. Mathad, MD, MSc (1)